The Current Ratio as of November 2024 (TTM) for Supernus Pharmaceuticals, Inc. (SUPN) is 2.20

According to Supernus Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.20. This represents a change of 16.47% compared to the average of 1.88 of the last 4 quarters.

Supernus Pharmaceuticals, Inc. (SUPN) Historical Current Ratio (quarterly & annually)

How has SUPN Current Ratio performed in the past?

The mean historical Current Ratio of Supernus Pharmaceuticals, Inc. over the last ten years is 2.28. The current 2.20 Current Ratio has changed 9.52% with respect to the historical average. Over the past ten years (40 quarters), SUPN's Current Ratio was at its highest in in the March 2018 quarter at 4.90. The Current Ratio was at its lowest in in the June 2022 quarter at 0.85.

Supernus Pharmaceuticals, Inc. (SUPN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Supernus Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Supernus Pharmaceuticals, Inc. (SUPN) Average Current Ratio

How has SUPN Current Ratio performed in the past?

The current Current Ratio of Supernus Pharmaceuticals, Inc. (SUPN) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Supernus Pharmaceuticals, Inc. (SUPN) Current Ratio vs. Peers

How is SUPN’s Current Ratio compared to its peers?

Supernus Pharmaceuticals, Inc.’s Current Ratio is less than Prestige Consumer Healthcare Inc. (3.56), greater than Evotec SE (2.09), greater than Collegium Pharmaceutical, Inc. (0.97), less than Deciphera Pharmaceuticals, Inc. (4.19), greater than Eagle Pharmaceuticals, Inc. (1.70), less than ANI Pharmaceuticals, Inc. (2.74), less than Phibro Animal Health Corporation (3.23), less than Pacira BioSciences, Inc. (2.25), greater than Dr. Reddy's Laboratories Limited (1.92), less than Silver Spike Investment Corp. (6.09), less than Regencell Bioscience Holdings Limited (41.92),

Build a custom stock screener for Supernus Pharmaceuticals, Inc. (SUPN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Supernus Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Supernus Pharmaceuticals, Inc. (SUPN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Supernus Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.